1. PET‐DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL). (12th June 2019) Authors: Balzarotti, M.; Ricardi, U.; Spina, M.; Monagheddu, C.; Tucci, A.; Cavallo, F.; Zanni, M.; Arcari, A.; Rusconi, C.; Sartori, R.; Merli, F.; Re, F.; Vitolo, U.; Dessi, D.; Melis, L.; Gaidano, G.; Chiti, A.; Deidda, M.; Santoro, A.; Ciccone, G. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The role of cryoablation in patients with metastatic breast cancer at the time of presentation. (October 2020) Authors: Fancellu, A.; Melis, L.; Ballicu, N.; Meloni, P.; Sanna, V.; Porcu, A.; Pusceddu, C. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0190 Synovial fluid derived invariant natural killer T cells in chronic arthritides show an increased programmed death-1 expression and anergic phenotype. (23rd January 2014) Authors: Venken, K.; Melis, L.; Jacques, P.; Van Praet, L.; De Bock, W.; Piette, Y.; van den Bosch, F.; Verbruggen, G.; Elewaut, D. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗